Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Victoria"

14 News Found

Zydus Lifesciences to launch protection against new strain of influenza virus
News | February 27, 2025

Zydus Lifesciences to launch protection against new strain of influenza virus

VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives


Jackson ImmunoResearch launches new antibodies and conjugates
News | November 26, 2024

Jackson ImmunoResearch launches new antibodies and conjugates

GFP is a common fusion protein tag that enables protein expression to be monitored, quantified, and localized within the complex environment of the cell


India reiterates commitment to adolescents on launch of ‘Economic Case for Investment in the Well-being of Adolescents in India’ report
Policy | July 29, 2024

India reiterates commitment to adolescents on launch of ‘Economic Case for Investment in the Well-being of Adolescents in India’ report

Report highlights significant improvements in adolescent well-being in India


Merck to showcase advances in the science of cancer with new data presented at ASCO 2024
News | May 24, 2024

Merck to showcase advances in the science of cancer with new data presented at ASCO 2024

Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors


ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV
Public Health | March 17, 2023

ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV

KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.


Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results
Biotech | April 21, 2022

Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results

Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both


Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Biotech | April 11, 2022

Moderna kickstarts Phase 1/2 study for influenza vaccine candidate

Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle


SK Biopharmaceuticals joins Pharmaceutical Supply Chain Initiative
Supply Chain | February 25, 2022

SK Biopharmaceuticals joins Pharmaceutical Supply Chain Initiative

PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains


Ribon Therapeutics appoints Prakash Raman as President and CEO
People | February 18, 2022

Ribon Therapeutics appoints Prakash Raman as President and CEO

Dr. Raman has succeeded Victoria Richon


Moderna announces expansion in key Asian markets
News | February 16, 2022

Moderna announces expansion in key Asian markets

New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong